A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
The University of Texas health Science Center at Houston
Clinical research site in Houston, Texas · 7500 CAMBRIDGE ST STE 3410, HOUSTON, TX 77054-2032 · (713) 500-8220 · Website
Part of University of Texas Health Science Center at Houston
As of July 2026, 162 paid clinical trials are recruiting at The University of Texas health Science Center at Houston in Houston, Texas. Active studies at this site cover conditions such as Systemic Sclerosis, HIV Infections and Systemic Lupus Erythematosus. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at The University of Texas health Science Center at Houston (162)
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
for Cognitive Dysfunction
42 locations incl. Chandler
Sponsor: Eli Lilly and Company
Sex: All·Age: 55 - 85
Code: NCT07589595·Phase 2·Recruiting·Listed May 2026
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
for Systemic Lupus Erythematosus
30 locations incl. Beverly Hills
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18 - 74
Code: NCT07409181·Phase 2·Recruiting·Listed Feb 2026
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
for Parkinson's Disease
26 locations incl. Phoenix
Sponsor: Bayer
Sex: All·Age: 45 - 75
Code: NCT07330258·Recruiting·Listed Jan 2026
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for Clostridioides Difficile Associated Disease
135 locations incl. Athens
Sponsor: Pfizer
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for Healthy
122 locations incl. Birmingham
Sponsor: Pfizer
Sex: All·Age: 1 Day - 49·Accepts healthy volunteers
Code: NCT07160244·Phase 3·Recruiting·Listed Sep 2025
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
for COVID-19 Infection
65 locations incl. Canoga Park
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07013474·Phase 3·Recruiting·Listed Jun 2025
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for Neoplasms
77 locations incl. Birmingham
Sponsor: Celgene
Sex: All·Age: All ages
Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
for COVID-19 SARS-CoV-2 Infection
81 locations incl. Little Rock
Sponsor: Pfizer
Sex: All·Age: 12+
Code: NCT06679140·Phase 3·Recruiting·Listed Nov 2024
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
for RSV Infection
81 locations incl. Birmingham
Sponsor: Pfizer
Sex: All·Age: 0+·Accepts healthy volunteers
Code: NCT06866405·Phase 3·Recruiting·Listed Mar 2025
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for Ulcerative Colitis
39 locations incl. Dothan
Sponsor: Takeda
Sex: All·Age: 18 - 65
Code: NCT06095128·Phase 4·Recruiting·Listed Oct 2023
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
for Parkinson Disease
45 locations incl. Sun City
Sponsor: Neuron23 Inc.
Sex: All·Age: 40 - 80
Code: NCT06680830·Phase 2·Recruiting·Listed Nov 2024
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for Crohn's Disease
42 locations incl. Dothan
Sponsor: Takeda
Sex: All·Age: 18 - 70
Code: NCT06045754·Phase 4·Recruiting·Listed Sep 2023
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
for Tricuspid Regurgitation
46 locations incl. Irvine
Sponsor: Edwards Lifesciences
Sex: All·Age: 18+
Code: NCT04097145·Recruiting·Listed Sep 2019
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
for Mitral Valve Regurgitation
69 locations incl. Birmingham
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18+
Code: NCT03242642·Recruiting·Listed Aug 2017
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
for Interstitial Lung Diseases
33 locations incl. Birmingham
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06806592·Phase 3·Recruiting·Listed Feb 2025
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
for Migraine
26 locations incl. Phoenix
Sponsor: Pfizer
Sex: All·Age: 12 - 17
Code: NCT06616194·Phase 3·Recruiting·Listed Sep 2024
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
for Abdominal Aortic Aneurysm
28 locations incl. Loma Linda
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 20+
Code: NCT05378347·Recruiting·Listed May 2022
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
for Aortic Stenosis
71 locations incl. Birmingham
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18 - 105
Code: NCT06777368·Recruiting·Listed Jan 2025
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
for Inflammatory Bowel Diseases
25 locations incl. Lancaster
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Sex: All·Age: 18 - 85
Code: NCT06226883·Phase 2·Recruiting·Listed Jan 2024
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
66 locations incl. Birmingham
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT06388421·Recruiting·Listed Apr 2024
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for Refractory Angina
65 locations incl. Phoenix
Sponsor: Shockwave Medical, Inc.
Sex: All·Age: 18+
Code: NCT05102019·Recruiting·Listed Nov 2021
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
for Systemic Lupus Erythematosus
23 locations incl. Aurora
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All·Age: 18+
Code: NCT05869955·Phase 1·Recruiting·Listed May 2023
PARTNER 3 Trial - Aortic Valve-in-Valve
for Aortic Stenosis
29 locations incl. Phoenix
Sponsor: Edwards Lifesciences
Sex: All·Age: All ages
Code: NCT03003299·Recruiting·Listed Dec 2016
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
for Smoking
15 locations incl. Rogers
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07223840·Phase 2·Recruiting·Listed Nov 2025
Diagnosing Epilepsy To EffeCT Change
for Epilepsy
19 locations incl. Phoenix
Sponsor: Epiminder America, Inc.
Sex: All·Age: 18 - 75
Code: NCT07110337·Recruiting·Listed Aug 2025
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
for Primary Mitochondrial Disease
20 locations incl. Orange
Sponsor: Pharming Technologies B.V.
Sex: All·Age: 18+
Code: NCT05650229·Phase 2·Recruiting·Listed Dec 2022
Onyx™ Liquid Embolic IDE Clinical Study
for Peripheral Arterial Hemorrhage
18 locations incl. Phoenix
Sponsor: Medtronic Endovascular
Sex: All·Age: 22+
Code: NCT06742801·Recruiting·Listed Dec 2024
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
for Gram-negative Bacterial Infection
11 locations incl. Orange
Sponsor: Pfizer
Sex: All·Age: Up to 39 Weeks
Code: NCT06462235·Phase 2·Recruiting·Listed Jun 2024
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
for Cerebral Vasospasm
16 locations incl. Burbank
Sponsor: Vesalio
Sex: All·Age: 22+
Code: NCT06893588·Recruiting·Listed Mar 2025
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
for Candidemia
23 locations incl. Birmingham
Sponsor: Basilea Pharmaceutica
Sex: All·Age: 18+
Code: NCT05421858·Phase 3·Recruiting·Listed Jun 2022
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
for Viral Pneumonia
22 locations incl. Sacramento
Sponsor: Synairgen Research Ltd.
Sex: All·Age: 18+
Code: NCT06999603·Phase 2·Recruiting·Listed May 2025
AltaValve Pivotal Trial
for Mitral Regurgitation
20 locations incl. Phoenix
Sponsor: 4C Medical Technologies, Inc.
Sex: All·Age: 18+
Code: NCT06465745·Recruiting·Listed Jun 2024
Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
for Lower Extremity Lymphedema
1 location in Houston
Sponsor: Tactile Medical
Sex: All·Age: 18+
Code: NCT07613931·EARLY_Phase 1·Recruiting·Listed May 29, 2026
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
for Colorectal Anastomosis
9 locations incl. New Haven
Sponsor: Medtronic - MITG
Sex: All·Age: 18+
Code: NCT07351071·Recruiting·Listed Jan 2026
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
for Glycogen Storage Disease Type Ia
9 locations incl. Orange
Sponsor: Ultragenyx Pharmaceutical Inc
Sex: All·Age: 2+
Code: NCT06636383·Recruiting·Listed Oct 2024
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
for Common Warts
6 locations incl. Saint Augustine
Sponsor: Verrica Pharmaceuticals Inc.
Sex: All·Age: 2+
Code: NCT07246590·Phase 3·Recruiting·Listed Nov 2025
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
for Mitochondrial Diseases
3 locations incl. Boston
Sponsor: Khondrion BV
Sex: All·Age: 18+
Code: NCT06451757·Phase 3·Recruiting·Listed Jun 2024
Clinical Outcome Measure at Stryker Spine
for Degenerative Disc Disease
7 locations incl. Jacksonville
Sponsor: VB Spine, LLC
Sex: All·Age: 18+
Code: NCT06226272·Recruiting·Listed Jan 2024
US Post-Market Surveillance Study of the Surfacer System
for Venous Disease
7 locations incl. Sarasota
Sponsor: Merit Medical Systems, Inc.
Sex: All·Age: 18+
Code: NCT05050799·Recruiting·Listed Sep 2021
Showing the 40 most relevant of 162 recruiting trials at this site. Browse all with filters →
More research sites in Houston
- MD Anderson Cancer Center (422 trials)
- M D Anderson Cancer Center (272 trials)
- Baylor College of Medicine (197 trials)
- The University of Texas MD Anderson Cancer Center (131 trials)
- Houston Methodist Hospital (128 trials)
- Texas Children's Hospital (113 trials)
- The University of Texas M. D. Anderson Cancer Center (85 trials)
- University of Texas MD Anderson Cancer Center (83 trials)
- UT MD Anderson Cancer Center (62 trials)
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center (58 trials)